Public Data
24 samples
A new understanding of the molecular pathway in human keloid fibroblasts and development of a novel treatment
Accession: SRP155769
Published: 2021 in Exp Dermatol
primary cells
bioactive entity
zone of skin
keloid
Public Data
8 samples
Transcription factors involved in drug resistance in acute lymphoblastic leukemia
Accession: SRP114317
Published: 2021
cell line
blood
acute lymphoblastic leukemia
Public Data
6 samples
Homo sapiens Raw sequence reads
Accession: SRP273203
Published: 2021
cell line
gene, gene: shrna
prostate gland
prostate cancer
Public Data
6 samples
RNA-seq of Human Limbal Epithelial Stem Cells and WNT16-treated Human Limbal Epithelial Stem Cells
Accession: SRP329243
Published: 2021
primary cells
bioactive entity
cornea, sclera
Public Data
9 samples
786-O, RNA seq
Accession: SRP329242
Published: 2021
cell line
gene, gene: overexpression
kidney
renal cell adenocarcinoma
Public Data
84 samples
UBE3A modulates Angelman syndrome transcriptome via retrovirus like GAG domain containing protein PEG10
Accession: SRP310075
Published: 2021 in Cell Rep Med
primary cells
blood
Angelman syndrome, None
Public Data
8 samples
RNA-Seq of isogenic human iPS cell-derived cardiomyocytes with RBM20 mutations created by genome editing (RiboMinus RNA-Seq)
Accession: SRP322106
Published: 2021 in Nat Commun
cell line
gene, gene: crispr
heart
Public Data
6 samples
Homo sapiens Raw sequence reads
Accession: SRP326005
Published: 2021
cell line
gene, gene: crispr
zone of skin
Public Data
6 samples
3' UTR RNA-sequencing of human EGFR-mutant PC9 cells that were CRISPR engineered to additionally contain EGFR-mutations T790M and C797S
Accession: ERP125683
Published: 2021
cell line
gene, gene: crispr
lung
lung cancer
Public Data
12 samples
3' UTR RNA-sequencing of human EGFR-mutant lung adenocarcinoma cell lines treated with trametinib or controls
Accession: ERP125687
Published: 2021
cell line
bioactive entity
lung
lung adenocarcinoma
Public Data
22 samples
3' UTR RNA-sequencing of oncogene-driven human cancer cell lines treated with a kinase inhibitor versus controls
Accession: ERP125680
Published: 2021
cell line
bioactive entity
breast, leg, ...
cancer
Public Data
16 samples
3' UTR RNA-sequencing of osimertinib vs. untreated Patient Derived Xenograft (PDX) models derived from EGFR-mutant lung tumors
Accession: ERP125685
Published: 2021
xenograft
bioactive entity
lung
lung adenocarcinoma
Public Data
36 samples
3' UTR RNA-sequencing of human EGFR-mutant lung cancer cell lines under osimertinib treatment
Accession: ERP125661
Published: 2021
cell line
bioactive entity
lung
lung adenocarcinoma
Public Data
12 samples
3' UTR RNA-seq of CRISPR-edited human EGFR-mutant PC9 lung cancer cell lines after osimertinib treatment
Accession: ERP125679
Published: 2021
cell line
bioactive entity, gene, ...
lung
lung adenocarcinoma
Public Data
16 samples
Prostate cancer tissue RNA-sequencing
Accession: SRP328993
Published: 2021
primary tissue
prostate gland
normal, prostate cancer